CHEK2 mutations and the risk of papillary thyroid cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Cancer

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.29426PMID 25583358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.

  2014cited by this paper
• Variants in the ATM‐CHEK2‐BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma

  2014cited by this paper
• Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

  2014cited by this paper
• The risk of gastric cancer in carriers of CHEK2 mutations

  2013cited by this paper
• Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma.

  2011cited by this paper
• Finding the missing heritability of complex diseases

  2009cited by this paper
• The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.

  2009cited by this paper
• The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype

  2009cited by this paper
• Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.

  2008cited by this paper
• Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer

  2008cited by this paper
• Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

  2007cited by this paper
• Is CHEK2 a cause of the Li–Fraumeni syndrome?

  2007cited by this paper
• Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

  2007cited by this paper
• Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study.

  2007cited by this paper
• CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.

  2006cited by this paper
• Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

  2006influential reference
• A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

  2006cited by this paper
• Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.

  2006cited by this paper
• Thyroid cancer and multiple primary tumors in the SEER cancer registries 1

  2005cited by this paper
• CHEK2 I157T associates with familial and sporadic colorectal cancer

  2005cited by this paper
• Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications

  2004cited by this paper
• The Chk2 protein kinase.

  2004cited by this paper
• CHEK2 is a multiorgan cancer susceptibility gene.

  2004influential reference
• A novel founder CHEK2 mutation is associated with increased prostate cancer risk.

  2004cited by this paper
• Chk1 and Chk2 kinases in checkpoint control and cancer.

  2003cited by this paper
• The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.

  2003cited by this paper
• Thyroid cancer pooled analysis from 14 case–control studies: what have we learned?

  2003cited by this paper
• The risk of multiple primary breast and thyroid carcinomas

  2003cited by this paper
• CHEK2 variants associate with hereditary prostate cancer

  2003cited by this paper
• Mutations in CHEK2 associated with prostate cancer risk.

  2003cited by this paper
• Second primary malignancies in thyroid cancer patients

  2003cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families

  2001cited by this paper
• The development of breast carcinoma in women with thyroid carcinoma

  2001cited by this paper
• Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study.

  2001cited by this paper
• Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States)

  2000cited by this paper
• Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.

  2000cited by this paper
• Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

  1999cited by this paper
• Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

  1999cited by this paper
• Incidence of breast carcinoma in women with thyroid carcinoma

  1999cited by this paper
• Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82.

  1985cited by this paper
• Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82.

  1985cited by this paper

• Mutations with prognostic value in uveal melanoma. Analytical study of variants detected by targeted NGS.

  2026cites this paper
• Ewing sarcoma and CHEK2-related tumor predisposition syndrome (case report and review)

  2025cites this paper
• Focal High-Grade Areas with a Tumor-in-Tumor Pattern: Another Feature of Pediatric DICER1-Associated Thyroid Carcinoma?

  2025cites this paper
• Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review

  2025cites this paper
• Familial Thyroid Cancers Syndromes.

  2025cites this paper
• Risk of lymphoid malignancy associated with cancer predisposition genes

  2025cites this paper
• Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma

  2025cites this paper
• Germline Mutations in DNA Repair Genes in Patients with Pancreatic Neuroendocrine Neoplasms: Diagnostic and Therapeutic Implications

  2025cites this paper
• 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer

  2025cites this paper
• Cancer spectrum in Mexican patients with the CHEK2 p.(Leu236Pro) variant: a retrospective study

  2025cites this paper
• Clinically Relevant Germline Variants in Children With Nonmedullary Thyroid Cancer

  2024cites this paper
• Identification of P21 (CDKN1A) Activated Kinase 4 as a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma

  2024cites this paper
• Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with CHEK2 Germline Mutations

  2024cites this paper
• Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing

  2024cites this paper
• CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function

  2024cites this paper
• CHEK2 Founder Variants and Thyroid Cancer Risk

  2024influential citation
• Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome

  2024cites this paper
• Selenium in Surgery

  2024cites this paper
• Protein-truncating and rare missense variants in ATM and CHEK2 and associations with cancer in UK Biobank whole-exome sequence data

  2024cites this paper
• Germline variant profiling of CHEK2 sequencing variants in breast cancer patients.

  2024cites this paper
• Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

  2024cites this paper
• Synchronous Papillary Thyroid Cancer and Colorectal Cancer in a Young Patient with a CHEK2 Mutation

  2024cites this paper
• A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predisposition

  2024cites this paper
• Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer

  2024cites this paper
• Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST/miR-93/HIF-1a pathway

  2023cites this paper
• CHEK2 variants, breast cancer, and implications for management: a narrative review

  2023cites this paper
• Comprehensive analysis of the functional impact of single nucleotide variants of human CHEK2

  2023cites this paper
• Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality

  2023cites this paper
• PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer

  2023cites this paper
• Incidentally Detected Metachronous Malignancy in Patients of Papillary Carcinoma of Thyroid Posthigh-Dose Radioiodine Therapy

  2023cites this paper
• Next‐generation sequencing of uveal melanoma with clinical and histological correlations: Prognostic value of new mutations in the PI3K/AKT/mTOR pathway

  2023cites this paper
• Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

  2023cites this paper
• The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study

  2023cites this paper
• Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition

  2022cites this paper
• Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2

  2022cites this paper
• An appraisal of genetic testing for prostate cancer susceptibility

  2022cites this paper
• Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D

  2022influential citation
• Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys

  2022cites this paper
• Risk of Second Primary Thyroid Cancer in Women with Breast Cancer

  2022cites this paper
• CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?

  2022cites this paper
• Modern concepts of the molecular pathogenesis of thyroid cancer

  2021cites this paper
• Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences

  2021cites this paper
• Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates

  2021cites this paper
• Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma

  2021cites this paper
• Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum

  2021cites this paper
• A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer

  2021cites this paper
• Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer

  2021cites this paper
• Disease spectrum of gastric cancer susceptibility genes

  2021cites this paper
• Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma

  2021cites this paper
• CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects

  2021cites this paper
• Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC)

  2021cites this paper
• The CHEK2*1100delC Mutation and Adolescent Breast Cancer: A Case Report of Breast Cancer in a 19-Year-Old and a Review of the Literature

  2021cites this paper
• Large contribution of copy number alterations in early stage of Papillary Thyroid Carcinoma

  2021cites this paper
• Deleterious Mutations in the TPO Gene Associated with Familial Thyroid Follicular Cell Carcinoma in Dutch German Longhaired Pointers

  2021influential citation
• Familial non medullary thyroid carcinoma: Beyond the syndromic forms.

  2021cites this paper
• Novel Driver Strength Index highlights important cancer genes in TCGA PanCanAtlas patients

  2021cites this paper
• A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer

  2021cites this paper
• Papillary thyroid cancer in a patient with germline CHEK2 mutation: a case report.

  2021cites this paper
• Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

  2021cites this paper
• Recurrent Acromegaly in a Patient With a CHEK2 Mutation

  2021cites this paper
• Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature).

  2021cites this paper
• Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics

  2021cites this paper
• Modern concepts of the molecular pathogenesis of thyroid cancer

  2021influential citation
• Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?

  2020cites this paper
• CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate

  2020cites this paper
• Effect of breast cancer as the first or second primary cancer on the prognosis of women with thyroid cancer: a SEER database analysis

  2020cites this paper
• Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?

  2020cites this paper
• Uveal melanoma-associated cancers revisited

  2020cites this paper
• Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer

  2020cites this paper
• Familial non medullary thyroid carcinoma: Beyond the syndromic forms.

  2020cites this paper
• Selenium Deficiency—From Soil to Thyroid Cancer

  2020cites this paper
• Feedback of extended panel sequencing in 1530 patients referred for suspicion of hereditary predisposition to adult cancers

  2020cites this paper
• Beyond BRCA1 and BRCA2: Deleterious Variants in DNA Repair Pathway Genes in Italian Families with Breast/Ovarian and Pancreatic Cancers

  2020cites this paper
• Is CHEK2 a moderate-risk breast cancer gene or the younger sister of Li-Fraumeni?

  2020cites this paper
• Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing.

  2020cites this paper
• Survival of bladder or renal cancer in patients with CHEK2 mutations

  2020cites this paper
• Disease Spectrum of Breast Cancer Susceptibility Genes

  2020cites this paper
• Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma

  2020cites this paper
• CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report

  2020cites this paper
• A case report of triple primary malignant tumors including breast,cervical and thyroid cancers with CHEK2 and PIK3CA mutation

  2020cites this paper
• Germline Mutation in MUS81 Resulting in Impaired Protein Stability is Associated with Familial Breast and Thyroid Cancer

  2020cites this paper
• A Novel CHEK2 Mutation May Drive Familial Papillary Thyroid Cancer

  2020cites this paper
• High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer.

  2020cites this paper
• A Germline CHEK2 Mutation in a Family with Papillary Thyroid Cancer

  2020cites this paper
• Ras-Mediated Activation of NF-κB and DNA Damage Response in Carcinogenesis

  2020cites this paper
• The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.

  2020cites this paper
• Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course

  2019cites this paper
• GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.

  2019cites this paper
• Exploration of the hub genes and miRNAs in lung adenocarcinoma

  2019cites this paper
• Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer

  2019cites this paper
• Human Mutation

  2019cites this paper
• Somatic genetic alterations in a large cohort of pediatric thyroid nodules

  2019cites this paper
• Identification of Rare Variants Predisposing to Thyroid Cancer

  2019cites this paper
• Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system

  2019cites this paper
• Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes

  2019cites this paper
• Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double‐edged Sword of Estrogen Receptor and Progesterone Receptor

  2018cites this paper
• Genetics of Breast and Ovarian Cancer Predisposition with a Focus on RAD51C and RAD51D Genes

  2018cites this paper
• Exploring Ob-Gyn providers' experience with and knowledge of multi-gene panels for hereditary breast and ovarian cancer

  2018cites this paper
• CHEK 2 SNPs predict better prognosis in HBV-related hepatocellular carcinoma patients

  2018cites this paper
• Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates

  2018influential citation